We value your privacy
We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.
Clinical Trials
1
0 active
Approvals
0
Total approvals
Agencies
Regulatory bodies
Founded
1995
Completed
100.0%
No approval data available
- IXICO PLC has appointed Tanya Voloshen as its first chief commercial officer to strengthen commercial capabilities and accelerate business development activities. - Voloshen will be based in Boston, Massachusetts, to help broaden IXICO's footprint in the US market for neuroscience imaging services. - The new CCO brings extensive commercial leadership experience from neuroscience and medical imaging companies including Perceptive Inc, Clario, QMENTA and ConcertAI. - The appointment reflects IXICO's commitment to growth in the clinical imaging market through its specialized neuroscience imaging and biomarker analytics platform.
